Vesa Hyrylä is a Senior Clinical Data Manager at Orion Corporation since November 2021, with prior experience as a Clinical Data Manager. Concurrently serving as a Visiting Researcher at the University of Eastern Finland since September 2017, Vesa is finalizing a PhD focusing on subclinical complications in Type 1 diabetes. Vesa has acted as Project Manager for the DIAMES and ILOX studies, supervised multiple theses, and contributed as a course assistant in Signal Analysis. Previous roles include Scientific Researcher at Kubios and Scientific Researcher at Kuopio University Hospital. Vesa holds a Master's degree in Engineering Physics/Applied Physics from the University of Eastern Finland.
This person is not in the org chart
Orion
1 followers
Orion is a globally operating Finnish pharmaceutical company – a builder of well-being. Orion develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company is continuously developing new drugs and treatment methods. The core therapy areas of Orion's pharmaceutical R&D are neurological disorders, oncology, Finnish heritage rare diseases and respiratory diseases for which Orion develops inhaled Easyhaler® pulmonary drugs.